NEW YORK (GenomeWeb) – MDxHealth today reported that its third quarter revenues increased 17 percent year over year, driven by sales of its ConfirmMDx for Prostate Cancer test.

The Belgian molecular diagnostics firm reported total revenues of $4.1 million for the three months ended Sept. 30, up from $3.5 million in the third quarter of 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.